Shanghai Allist Pharmaceuticals Co., Ltd. (SHA:688578)
China · Delayed Price · Currency is CNY 97.00
-1.07 (-1.09%)
At close: Feb 6, 2026
SHA:688578 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Net Income | 1,983 | 1,430 | 644.17 | 130.52 | 18.27 | -310.52 |
Depreciation & Amortization | 38.61 | 38.61 | 39.39 | 25.25 | 23.46 | 11.86 |
Other Amortization | 1.19 | 1.19 | 0.79 | 1.77 | 2.42 | 0.63 |
Loss (Gain) From Sale of Assets | - | - | -0.02 | -0.03 | - | - |
Asset Writedown & Restructuring Costs | 0.01 | 0.01 | 0.03 | 1.71 | -34.53 | 0.02 |
Loss (Gain) From Sale of Investments | -36.65 | -36.65 | -32.58 | -45.01 | -66.01 | -23.7 |
Stock-Based Compensation | - | - | - | - | - | 71.62 |
Provision & Write-off of Bad Debts | 0.16 | 0.16 | -0.71 | 1.36 | 0.5 | -0.02 |
Other Operating Activities | -103.13 | -44.15 | -36.02 | -29.53 | 4.72 | 1.19 |
Change in Accounts Receivable | -186.03 | -186.03 | -163.84 | -108.57 | 8.22 | -1.3 |
Change in Inventory | 32.39 | 32.39 | -30.88 | -10.62 | -12.34 | -10.53 |
Change in Accounts Payable | 238.62 | 238.62 | 184.14 | 67.38 | 10.89 | 64.01 |
Change in Other Net Operating Assets | 78.26 | 78.26 | 75.03 | 68.91 | 73.69 | - |
Operating Cash Flow | 2,060 | 1,566 | 674.65 | 91.63 | 29.29 | -196.75 |
Operating Cash Flow Growth | 42.13% | 132.12% | 636.28% | 212.82% | - | - |
Capital Expenditures | -178.78 | -270.22 | -67.88 | -143.83 | -192.25 | -88.45 |
Sale of Property, Plant & Equipment | - | - | - | 0 | - | - |
Investment in Securities | -956.6 | -956.6 | 1,416 | 81.63 | 599.99 | -1,671 |
Other Investing Activities | -187.83 | -608.35 | -1,255 | -342.02 | -168.56 | 16.67 |
Investing Cash Flow | -1,323 | -1,835 | 92.75 | -404.21 | 239.19 | -1,743 |
Long-Term Debt Repaid | - | -2.38 | -2.58 | -4.87 | -8.97 | -110 |
Total Debt Repaid | -2.38 | -2.38 | -2.58 | -4.87 | -8.97 | -110 |
Net Debt Issued (Repaid) | -2.38 | -2.38 | -2.58 | -4.87 | -8.97 | -110 |
Issuance of Common Stock | - | - | - | - | - | 1,943 |
Common Dividends Paid | -360 | -292.5 | - | - | - | -1.19 |
Other Financing Activities | -0.46 | -0.16 | 0.37 | 1.19 | -8 | 80.91 |
Financing Cash Flow | -362.85 | -295.05 | -2.21 | -3.69 | -16.97 | 1,913 |
Foreign Exchange Rate Adjustments | 1.99 | 2.84 | 4.35 | 17.17 | -3.38 | -0.35 |
Net Cash Flow | 375.81 | -561.36 | 769.55 | -299.1 | 248.13 | -26.74 |
Free Cash Flow | 1,881 | 1,296 | 606.77 | -52.21 | -162.95 | -285.2 |
Free Cash Flow Growth | 54.29% | 113.56% | - | - | - | - |
Free Cash Flow Margin | 39.54% | 36.42% | 30.06% | -6.60% | -30.74% | -50847.96% |
Free Cash Flow Per Share | 4.19 | 2.88 | 1.35 | -0.12 | -0.36 | -0.77 |
Cash Income Tax Paid | 930.57 | 566.32 | 243.72 | 12.82 | -15.03 | 2.73 |
Levered Free Cash Flow | 1,431 | 822.62 | 378.35 | -56.71 | -120.89 | -204.99 |
Unlevered Free Cash Flow | 1,431 | 822.66 | 378.45 | -56.5 | -120.51 | -204.28 |
Change in Working Capital | 177 | 177 | 59.58 | 5.59 | 80.45 | 52.17 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.